Article
Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Apr 2007
Paraskevakou Georgia, Allen Cory, Nakamura Takafumi, Zollman Paula, James C David, Peng Kah Whye, Schroeder Mark, Russell Stephen J, Galanis Evanthia
Abstract excerpt
A retargeted measles virus strain MV-GFP-H(AA)-scEGFR was generated by engineering the MV-NSe Edmonston vaccine strain to incorporate both CD46 (Y481A) and signaling lymphocyte activation molecule (SLAM) (R533A) ablating mutations in the hemagglutinin protein in combination with the display of a single-chain antibody against epidermal growth factor receptor (EGFR) at the C terminus of hemagglutinin. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
